Delsam Pharma® Artificial Tears Eye Infection Investigation

Delsam eye drops recall and Investigation

Photo Credit: Unsplash | Updated: June 22, 2023

Claim Form Deadline: Ongoing

Estimated Payout: Varies

Proof required: Yes

Did you use Delsam Pharma artificial tears to treat dry or irritated eyes? Did you get an eye infection?

Delsam Pharma Artificial Tears Linked to Infections

Simmons Hanly Conroy, a National Law Firm, along with its affiliated firm, Siri & Glimstad LLP, is investigating claims that Delsam Care Artificial Tears Lubricant Eye Drops caused eye infections in people who used them. Delsam Care is sold over the counter to relieve dry and irritated eyes. Recently, there have been a significant number of cases where people developed antibiotic-resistant eye infections following use of artificial tears. Some infections became so severe they led to permanent vision loss, hospitalization and even death when an infection got into the bloodstream.

In February 22, 2023, a nationwide recall was reported on Delsam Pharma artificial eye ointment. The FDA has also issued a warning to consumers and health care specialists to discontinue purchasing and cease using Delsam Pharma Artificial Tears and Eye Ointment. The CDC reported a bacterial outbreak related to Delsam Pharma eye ointments.

According to the CDC and the FDA, some of these specific Delsam tear drop products are liable to lead to serious consumer injuries that might include some of the following:

• Severe Eye Damage,
• Vision Loss,
• Serious Bacterial Infections,
• Death.

As part of the recall investigations and announcements, Delsam has taken every possible step in order to notify consumers of the serious potential consequences of continuing use of the Delsam eye drops. Possible symptoms of infection from Delsam eye drops can be:

• Eye pain or discomfort,
• Headaches,
• Vision problems.

The FDA recall website urges consumers to reach out via the Delsam eye drops recall information hotline using the following number: 516-715-5181. Health care professionals are being encouraged to report any quality issues with these eye drops, as well as any adverse effects to patients and consumers by reaching out to the FDA, or calling the above number for the FDA hotline. The FDA has an online reporting system for medical recalls such as the Delsam eye drop consumer recall, called MedWatch. Consumers can also reach out and report negative interactions with Delsam using the FDA consumer complaint site.

Additionally, the CDC has issued a warning that Delsam Pharma eye drops and eye ointments were reported to contain a certain strain of anti-biotic resistant bacteria. The CDC conducted extensive lab tests, which successfully identified the presence of this bacteria, known as "VIM-GES-CRPA" in certain bottles of Delsam Pharma artificial tear products, from several different batches of products. The bottles were received from consumers with and without eye infections after having consumed the Delsam Pharma dry eye products.

How Do I Qualify?

If you suffered an eye infection following the use of Delsam Pharma artificial tears, reach out below. The Attorneys at Siri & Glimstad are working to help those who were injured as a result of Delsam Pharma artificial tears product use. There is a limited amount of time to act as these investigations are moving forward quickly. Please fill out the questionnaire if you believe you qualify, and a representative from the Siri & Glimstad law firm will review your case and contact you if they find that you are qualified. If you do not qualify for the Delsam Pharma artificial tears investigation, there is a similar investigation over another brand of eye drops and artificial tears called EzriCare.